Targeting tumor cells

This publication has 22 references indexed in Scilit:

• Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment
  Leukemia, 2003
• The genetics and genomics of cancer
  Nature Genetics, 2003
• Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias
  The Lancet Oncology, 2003
• Antibody-based therapeutics in oncology
  Expert Review of Anticancer Therapy, 2003
• HER-2 Inhibitors: Clinical Results
  Tumori Journal, 2002
• Infliximab
  BioDrugs, 2002
• Engineered antibodies take center stage
  Human Antibodies, 2001
• Human antibodies as next generation therapeutics
  Current Opinion in Chemical Biology, 2001
• Protein engineering techniques for antibody humanization
  Current Opinion in Biotechnology, 1994
• Derivation of specific antibody‐producing tissue culture and tumor lines by cell fusion
  European Journal of Immunology, 1976